Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Edwards Lifesciences (NYSE:EW) in the last three months. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. The 12-month price targets, analyzed by analysts, offer insights with an average target of $74.33, a high estimate of $90.00, and a low estimate of $66.00. This current average has decreased by 11.23% from the previous average price target of $83.73. Diving into A…